Seniors in Care Facilities Have More Protection Available This Year

CDC Encourages Vaccination Against Flu, COVID-19 and RSV

Translate to Spanish or other 102 languages!

This year, for the first time, vaccines are available to protect older adults in the United States against all three fall/winter respiratory illnesses: flu, COVID-19 and RSV. Older Americans who are not vaccinated are at greater risk of serious illness. Image for illustration purposes
This year, for the first time, vaccines are available to protect older adults in the United States against all three fall/winter respiratory illnesses: flu, COVID-19 and RSV. Older Americans who are not vaccinated are at greater risk of serious illness. Image for illustration purposes
- Advertisement -

New research in this week’s MMWR finds that most nursing home residents haven’t received an updated COVID-19 vaccine or the new RSV vaccine.

This year, for the first time, vaccines are available to protect older adults in the United States against all three fall/winter respiratory illnesses: flu, COVID-19 and RSV. Older Americans who are not vaccinated are at greater risk of serious illness.

Leading up to this virus season, and throughout the fall, CDC has worked with other federal agencies, state and local health departments, and health care partners to address vaccine access issues and encourage uptake. CDC was a key participant in the Long Term Care Facility Summit on October 18, 2023, which was co-hosted by the Secretary of Health and Human Services and the Director of the Office of Pandemic Preparedness and Response Policy. In addition to other activities, CDC regularly:

- Advertisement -
  • Monitors all reports and data about the safety and effectiveness of these vaccines.
  • Convenes bi-weekly calls with long-term care partners to address challenges/develop solutions.
  • Works to improveequitable access to vaccines by connecting manufacturers with long-term care pharmacies to prioritize vaccine distribution for the Bridge Access Program.
  • Distributes a weekly newsletter with respiratory virus resources and information specific to long-term care providers. (e.g., toolkits, FAQs, clinical resources, vaccine confidence resources)
  • Supports the education of partners through participation in speaking engagements and webinars.
  • Engages with the Centers for Medicare and Medicaid Services (CMS) toidentify solutions to address feedback from long-term care  partners around billing and reimbursement challenges which have been a barrier to vaccine administration. As a result, CMS issued a letter to plans and pharmacy benefit managers to outline the concerns and provide guidance on ways to improve practices.

Health care providers can continue to do their part by offering recommended vaccinations to residents. Nursing homes are encouraged to collaborate with state, local and federal public health, and long-term care pharmacy partners to address barriers contributing to low vaccination coverage. Vaccination is a key way to prevent severe disease, hospitalization, and death from flu, COVID-19 and RSV.

Information source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

Three Everyday Habits That Could Be Ruining Your Sleep

 If you struggle to get a good night’s sleep, you may want to look at some of your habits – like what time you actually go to bed.

When GLP‑1s Fall Short

Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonistsTrusted Source have been growing in popularity for not only treating type 2 diabetes but also for weight loss. 
- Advertisement -